Shobha's Memorial Fund
In honor of Shobha’s memory, please consider donating to her memorial fund at the Neuroscience Research Center at Saint John's Hospital to support brain cancer research. We are greatly indebted to Shobha's team at St John's, who gave us two more good years with her. We would love to raise funds for their research so that they can provide such exemplary care to many families.
We are also raising funds for CancerCommons, a free service which helps advanced cancer patients find treatment options. They helped us every step of the way and are a wonderful service.
There are 3 ways to donate.
PUMP IT UP!!!
Triple your donation
through a matching program:
Email to donate. Your donation will be tripled!
Double your donation through
your employer matching program:
2. Under the Designation dropdown, select Neuroscience Research Center
3. Check Tribute Gift and enter note 'Shobha Reddy'.
4. Submit your email receipt to your company with the following: "Tax id: 95-6100079; Saint John's Hospital and Health Center Foundation; Tribute gift for Shobha Reddy to the Neuroscience Research Center"
Donate through your foundation:
1. Please use the following information.
a. EIN: 95-6100079
b. Charity name: Saint John's Hospital and Health Center Foundation
c. Address: 2121 Santa Monica Blvd Santa Monica CA 90404
d. Note: Please direct funds to Neuroscience Research Center. This is a tribute gift in honor and memory of Shobha Reddy.
2. Email once the check is mailed so the hospital can look out for it.
About the Neuroscience Research Center
The mission of the Pacific Neuroscience Research Center under the direction of Santosh Kesari, MD, PhD is to accelerate the development of novel therapies for glioblastoma through genomics, drug innovations, and efficient clinical trials. More than 18,000 Americans develop a brain or neurologic tumor annually. Dr. Kesari’s research focuses on integrating basic, preclinical and clinical science to improve the understanding of brain tumor biology leading to customized patient treatments. By combining laboratory and clinical data through translational research programs, he strives to provide improved individually tailored therapies for patients living with malignant gliomas and other brain tumors. Equally important, he seeks to find patient-specific therapies that help reduce the toxicity of treatments and improve the quality of life for patients and caregivers. Dr. Kesari and his team also provide innovative clinical trials for patients including those with primary brain tumors, as well as patients with cancers that have metastasized to the brain from primary cancers such as breast, lung, and skin. Clinical trials like these offer the best hope for curing brain cancer.